First Anniversary Videos
Uscom awarded US blood flow measurement patent
TOP News
Source: News Bites
Medical device company Uscom Ltd has received a US patent for combining blood flow measurement with oximetry to non-invasively and accurately measure the amount of oxygen being delivered to the cells of the body.
The patent provides protection for the company's Oxycom device, which may be useful in clinical applications such as paediatrics, intensive care and emergency medicine, and anaesthesia.
Uscom says the patent forms the commercial protection for a pipeline of new devices planned for development and is a significant part of a shareholder value. Adding that it has over 30 patents and intellectual protection applications in various stages of recognition around the world.
The patent author and chairman Rob Phillips said “Oxygen delivery is a critical measure of the effectiveness of the circulation, and reflects the severity of cardiovascular disease. The new Oxycom product, currently in testing, provides this information non-invasively and beat to beat; a first in the world of physiology and medicine.”
CEO Paul Butler said “Intellectual property represents a significant component of the value of Uscom, and patents provide commercial protection for future product developments. This patent and the product it protects provide a great opportunity for Uscom to strengthen its position in the cardiovascular device marketplace and increase the value of the company.”
STOCK DASHBOARD: August 07, 2008
Uscom
Last traded August 05, 2008: 26.0c
Price change from previous trading day: -3.7%
Relative Strength (6 months percentile rank): 30.9
Market capitalisation: $10 million
Turnover volume: 18,590.0
Volume Index (1 is average): 1.9
Turnover value: $5,004
Turnover period: 15 years 3 months
Value of $1,000 invested 1 year ago: $722
Source: www.BuySellTips.com
Share This Story
Related Industry SectorsView the latest stories on Health & Pharmaceuticals
Related CompaniesView all stories on USCOM